GH Research Plc (GHRS)

20.95 -1.49 (-6.64%) USD  |  NASDAQ  |  May 07, 11:41
More

GH Research SG&A Expense (TTM) : 21.95M for Dec. 31, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for GHRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Definium Therapeutics, Inc. 48.64M
Compass Pathways Plc 60.72M
Atai Beckley, Inc. 65.09M
Jazz Pharmaceuticals Plc 1.295B
Nektar Therapeutics 68.67M